Renovaro Biosciences Denmark ApS — Credit Rating and Financial Key Figures

Renovaro Biosciences Denmark ApS (CVR number: 26027322) is a company from HØRSHOLM. The company recorded a gross profit of -80.1 kDKK in 2023. The operating profit was -148 kDKK, while net earnings were -6218.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0.2 %, which can be considered poor and Return on Equity (ROE) was -434.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -98.4 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Renovaro Biosciences Denmark ApS's liquidity measured by quick ratio was 5.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.